Evidence map›Paper›PMID 29797445›Full record

ArticlePediatric diabetes2018

Hope and mealtime insulin boluses are associated with depressive symptoms and glycemic control in youth with type 1 diabetes mellitus.

Alison K Calkins-Smith, Arwen M Marker, Mark A Clements, Susana R Patton

Abstract read
In one paragraph

Article in Pediatric diabetes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alison K Calkins-SmithClinical Psychology Program, University of Kansas, Lawrence, Kansas.
Arwen M MarkerClinical Child Psychology Program, University of Kansas, Lawrence, Kansas.ORCID 0000-0002-3024-3527
Mark A ClementsPediatric Clinical Research Unit, Children's Mercy Hospital, Kansas City, Missouri.
Susana R PattonDivision of Child Behavioral Health, University of Kansas Medical Center, Kansas City, Kansas.
University of Kansas · USChildren's Mercy Hospital · USUniversity of Kansas Medical Center · US

Funding

Longitudinal test of adherence & control in kids new to T1 diabetes & 5-9 yrs oldR01DK100779 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NELSON, EVE-LYNN · 2014 to 2018
$1.8M
An interactive mHealth app for better glycemic control in families of young kids with T1DDP3DK108211 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NELSON, EVE-LYNN · 2015 to 2015
$1.0M
Diabetes Institute at the University of Kansas Medical CenterNIDDK NIH HHS DP3 DK108211NIDDK NIH HHS R01 DK100779
6 · The paper itself

Abstract

Adherence to treatment regimen is associated with improved glycemic control and is particularly problematic during adolescence for those with type 1 diabetes mellitus (T1DM). Both glycemic control and adherence may be negatively impacted by poor psychological outcomes in adolescence, such as depressive symptoms and low hopefulness. The purpose of this study was to examine associations between the mealtime insulin bolus score (BOLUS), a more robust proxy measure of adherence than frequency of blood glucose monitoring or self-report, with depressive symptoms, hope, and hemoglobin A1c (HbA1c). Ninety adolescents completed measures of hope (Children's Hope Scale) and depressive symptoms (Center for Epidemiologic Studies-Depression Scale), as well as lab-based measures of HbA1c and mealtime insulin bolus scores (BOLUS). Higher levels of hope were associated with lower levels of depressive symptoms, more frequent mealtime insulin boluses, and better glycemic control. Higher levels of BOLUS behavior were associated with lower depressive symptoms and better glycemic control. Both BOLUS behavior and hope independently and significantly impacted the relationship between depressive symptoms and HbA1c, suggesting a possible mediation. Since hope and BOLUS were each associated with the relationship between depressive symptoms and glycemic control, following confirmation of this relationship in a longitudinal study, clinics may consider measuring hope and BOLUS among youth with high depressive symptoms and further investigating BOLUS behavior and hope as potential intervention targets to improve glycemic control.

Indexed as

Blood GlucoseMedication AdherenceAdolescentChildCross-Sectional StudiesDepressionDiabetes Mellitus, Type 1FemaleHopeHumansHypoglycemic AgentsInsulinMaleBlood GlucoseHypoglycemic AgentsInsulinadherencebolushopetype 1 diabetes mellitus

Identifiers

PMID29797445
PMCPMC6175638
OpenAlexW2803449403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.